scholarly article | Q13442814 |
P50 | author | Chelsea Pinnix | Q62592626 |
Erik P Sulman | Q88044412 | ||
Nandita Guha-Thakurta | Q41599067 | ||
P2093 | author name string | Paul D Brown | |
Anita Mahajan | |||
Sujit S Prabhu | |||
Pamela K Allen | |||
Eric L Chang | |||
Neil Parikh | |||
Dershan Luo | |||
Anna Likhacheva | |||
Almon Shiu | |||
Mary McAleer | |||
Max Chiu | |||
P2860 | cites work | A randomized trial of surgery in the treatment of single metastases to the brain | Q49096659 |
Radiosurgery for Intracranial Malignancies | Q73548693 | ||
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 | Q73764877 | ||
Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery. Clinical article | Q30450369 | ||
Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. | Q30724443 | ||
Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. | Q30838985 | ||
Radiosurgery for brain metastases: a score index for predicting prognosis | Q30848072 | ||
Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases | Q30881868 | ||
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial | Q31065424 | ||
Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients | Q33284025 | ||
Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases | Q33301921 | ||
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. | Q33302366 | ||
Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site | Q33397593 | ||
Evidence-based clinical practice parameter guidelines for the treatment of patients with metastatic brain tumors: introduction | Q33599182 | ||
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study | Q34679120 | ||
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases | Q35721137 | ||
Brain metastases: epidemiology and pathophysiology. | Q36282137 | ||
Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? | Q36783402 | ||
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials | Q36857456 | ||
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline | Q37256355 | ||
The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Q37644237 | ||
Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy | Q37825115 | ||
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial | Q38406445 | ||
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. | Q39925540 | ||
Radiosurgery with the world's first fully robotized Leksell Gamma Knife PerfeXion in clinical use: a 200-patient prospective, randomized, controlled comparison with the Gamma Knife 4C. | Q40005499 | ||
Stereotactic radiosurgical treatment of brain metastases | Q46126527 | ||
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial | Q46388451 | ||
What is your patient's GPA and why does it matter? Managing brain metastases and the cost of hope | Q47612343 | ||
Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases | Q48207291 | ||
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial | Q48353715 | ||
A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. | Q49041491 | ||
P304 | page(s) | 38-44 | |
P577 | publication date | 2012-12-01 | |
P1433 | published in | Journal of Neurosurgery | Q15708886 |
P1476 | title | Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone | |
P478 | volume | 117 Suppl |
Q47742544 | Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era? |
Q48011082 | Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease |
Q35960438 | Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases? |
Q42746047 | Dose-Volume Response Relationship for Brain Metastases Treated with Frameless Single-Fraction Linear Accelerator-Based Stereotactic Radiosurgery |
Q36199913 | Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases |
Q35776489 | Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer |
Q92318252 | Prognostic factors of brain metastases from colorectal cancer |
Q59813039 | Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity |
Q49355925 | Resection cavity radiosurgery for intracranial metastases: a review of the literature |
Q36428221 | Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA). |
Q38228670 | Stereotactic radiosurgery (SRS) for brain metastases: a systematic review |
Q36750637 | The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma |
Search more.